These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 37892158)

  • 21. The interplay between Glucocerebrosidase, α-synuclein and lipids in human models of Parkinson's disease.
    Muñoz SS; Petersen D; Marlet FR; Kücükköse E; Galvagnion C
    Biophys Chem; 2021 Jun; 273():106534. PubMed ID: 33832803
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Elevated concentrations cause upright alpha-synuclein conformation at lipid interfaces.
    Roeters SJ; Strunge K; Pedersen KB; Golbek TW; Bregnhøj M; Zhang Y; Wang Y; Dong M; Nielsen J; Otzen DE; Schiøtt B; Weidner T
    Nat Commun; 2023 Sep; 14(1):5731. PubMed ID: 37723164
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Unraveling amyloid formation paths of Parkinson's disease protein α-synuclein triggered by anionic vesicles.
    Kiskis J; Horvath I; Wittung-Stafshede P; Rocha S
    Q Rev Biophys; 2017 Jan; 50():e3. PubMed ID: 29233215
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Wild-type GBA1 increases the α-synuclein tetramer-monomer ratio, reduces lipid-rich aggregates, and attenuates motor and cognitive deficits in mice.
    Glajch KE; Moors TE; Chen Y; Bechade PA; Nam AY; Rajsombath MM; McCaffery TD; Dettmer U; Weihofen A; Hirst WD; Selkoe DJ; Nuber S
    Proc Natl Acad Sci U S A; 2021 Aug; 118(31):. PubMed ID: 34326260
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of curvature and composition on α-synuclein binding to lipid vesicles.
    Middleton ER; Rhoades E
    Biophys J; 2010 Oct; 99(7):2279-88. PubMed ID: 20923663
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Glycation of α-synuclein hampers its binding to synaptic-like vesicles and its driving effect on their fusion.
    Uceda AB; Frau J; Vilanova B; Adrover M
    Cell Mol Life Sci; 2022 Jun; 79(6):342. PubMed ID: 35662377
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pre-fibrillar alpha-synuclein variants with impaired beta-structure increase neurotoxicity in Parkinson's disease models.
    Karpinar DP; Balija MB; Kügler S; Opazo F; Rezaei-Ghaleh N; Wender N; Kim HY; Taschenberger G; Falkenburger BH; Heise H; Kumar A; Riedel D; Fichtner L; Voigt A; Braus GH; Giller K; Becker S; Herzig A; Baldus M; Jäckle H; Eimer S; Schulz JB; Griesinger C; Zweckstetter M
    EMBO J; 2009 Oct; 28(20):3256-68. PubMed ID: 19745811
    [TBL] [Abstract][Full Text] [Related]  

  • 28. N-alpha-acetylation of α-synuclein increases its helical folding propensity, GM1 binding specificity and resistance to aggregation.
    Bartels T; Kim NC; Luth ES; Selkoe DJ
    PLoS One; 2014; 9(7):e103727. PubMed ID: 25075858
    [TBL] [Abstract][Full Text] [Related]  

  • 29. From a Highly Disordered to a Metastable State: Uncovering Insights of α-Synuclein.
    Cote Y; Delarue P; Scheraga HA; Senet P; Maisuradze GG
    ACS Chem Neurosci; 2018 May; 9(5):1051-1065. PubMed ID: 29451381
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Sphingolipid changes in Parkinson L444P GBA mutation fibroblasts promote α-synuclein aggregation.
    Galvagnion C; Marlet FR; Cerri S; Schapira AHV; Blandini F; Di Monte DA
    Brain; 2022 Apr; 145(3):1038-1051. PubMed ID: 35362022
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Interaction of α-synuclein with biomembranes in Parkinson's disease--role of cardiolipin.
    Ghio S; Kamp F; Cauchi R; Giese A; Vassallo N
    Prog Lipid Res; 2016 Jan; 61():73-82. PubMed ID: 26703192
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Toxic properties of microsome-associated alpha-synuclein species in mouse primary neurons.
    Colla E; Panattoni G; Ricci A; Rizzi C; Rota L; Carucci N; Valvano V; Gobbo F; Capsoni S; Lee MK; Cattaneo A
    Neurobiol Dis; 2018 Mar; 111():36-47. PubMed ID: 29246724
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Exploring the Roles of Post-Translational Modifications in the Pathogenesis of Parkinson's Disease Using Synthetic and Semisynthetic Modified α-Synuclein.
    Chen H; Zhao YF; Chen YX; Li YM
    ACS Chem Neurosci; 2019 Feb; 10(2):910-921. PubMed ID: 30628768
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Library-Derived Peptide Aggregation Modulators of Parkinson's Disease Early-Onset α-Synuclein Variants.
    Watt KJC; Meade RM; Williams RJ; Mason JM
    ACS Chem Neurosci; 2022 Jun; 13(12):1790-1804. PubMed ID: 35613323
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Foldamers reveal and validate therapeutic targets associated with toxic α-synuclein self-assembly.
    Ahmed J; Fitch TC; Donnelly CM; Joseph JA; Ball TD; Bassil MM; Son A; Zhang C; Ledreux A; Horowitz S; Qin Y; Paredes D; Kumar S
    Nat Commun; 2022 Apr; 13(1):2273. PubMed ID: 35477706
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cell models of lipid-rich α-synuclein aggregation validate known modifiers of α-synuclein biology and identify stearoyl-CoA desaturase.
    Imberdis T; Negri J; Ramalingam N; Terry-Kantor E; Ho GPH; Fanning S; Stirtz G; Kim TE; Levy OA; Young-Pearse TL; Selkoe D; Dettmer U
    Proc Natl Acad Sci U S A; 2019 Oct; 116(41):20760-20769. PubMed ID: 31548371
    [TBL] [Abstract][Full Text] [Related]  

  • 37. α-Synuclein O-GlcNAcylation alters aggregation and toxicity, revealing certain residues as potential inhibitors of Parkinson's disease.
    Levine PM; Galesic A; Balana AT; Mahul-Mellier AL; Navarro MX; De Leon CA; Lashuel HA; Pratt MR
    Proc Natl Acad Sci U S A; 2019 Jan; 116(5):1511-1519. PubMed ID: 30651314
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The N-terminal Acetylation of α-Synuclein Changes the Affinity for Lipid Membranes but not the Structural Properties of the Bound State.
    Runfola M; De Simone A; Vendruscolo M; Dobson CM; Fusco G
    Sci Rep; 2020 Jan; 10(1):204. PubMed ID: 31937832
    [TBL] [Abstract][Full Text] [Related]  

  • 39. α-Synuclein and neuronal membranes: Conformational flexibilities in health and disease.
    Bozelli JC; Kamski-Hennekam E; Melacini G; Epand RM
    Chem Phys Lipids; 2021 Mar; 235():105034. PubMed ID: 33434528
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Membrane interactions of oligomeric alpha-synuclein: potential role in Parkinson's disease.
    van Rooijen BD; Claessens MM; Subramaniam V
    Curr Protein Pept Sci; 2010 Aug; 11(5):334-42. PubMed ID: 20423294
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.